Insider Trading & Ownership - Chung Jane

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Chung Jane

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2024-08-09
Tax Withholding		2024-08-13
4:16 pm		N/A
N/A		SUTRO BIOPHARMA INC.STROChung Jane
PRESIDENT AND COO		6,689$3.1273,012
(Direct)		View
2024-08-09
Exercise		2024-08-13
4:16 pm		N/A
2025-08-09		SUTRO BIOPHARMA INC.STROChung Jane
PRESIDENT AND COO		18,750$073,012
(Direct)		View
2024-06-20
Option Award		2024-06-24
7:48 pm		N/A
2034-06-20		Viracta Therapeutics Inc.VIRXChung Jane
Director		50,000$050,000
(Direct)		View
2024-03-05
Option Award		2024-03-07
4:26 pm		N/A
2034-03-05		SUTRO BIOPHARMA INC.STROChung Jane
PRESIDENT AND COO		150,000$0150,000
(Direct)		View
2024-03-04
Exercise		2024-03-06
4:21 pm		N/A
2026-03-04		SUTRO BIOPHARMA INC.STROChung Jane
PRESIDENT AND COO		7,875$057,951
(Direct)		View
2024-03-04
Tax Withholding		2024-03-06
4:21 pm		N/A
N/A		SUTRO BIOPHARMA INC.STROChung Jane
PRESIDENT AND COO		2,209$4.7957,951
(Direct)		View
2024-03-01
Tax Withholding		2024-03-05
4:32 pm		N/A
N/A		SUTRO BIOPHARMA INC.STROChung Jane
PRESIDENT AND COO		2,038$4.9557,160
(Direct)		View
2024-03-01
Exercise		2024-03-05
4:32 pm		N/A
2027-03-01		SUTRO BIOPHARMA INC.STROChung Jane
PRESIDENT AND COO		6,875$057,160
(Direct)		View
2023-12-01
Option Award		2023-12-04
4:19 pm		N/A
2033-12-01		SUTRO BIOPHARMA INC.STROChung Jane
President and COO		135,000$0135,000
(Direct)		View
2023-08-09
Tax Withholding		2023-08-11
4:16 pm		N/A
N/A		SUTRO BIOPHARMA INC.STROChung Jane
Chief Commercial Officer		6,483$4.2269,198
(Direct)		View
2023-08-09
Exercise		2023-08-11
4:16 pm		N/A
2025-08-09		SUTRO BIOPHARMA INC.STROChung Jane
Chief Commercial Officer		18,750$069,198
(Direct)		View
2023-06-08
Option Award		2023-06-09
6:19 pm		N/A
2033-06-08		Viracta Therapeutics Inc.VIRXChung Jane
Director		40,000$040,000
(Direct)		View
2023-03-03
Option Award		2023-03-07
4:26 pm		N/A
2033-02-28		SUTRO BIOPHARMA INC.STROChung Jane
Chief Commercial Officer		67,500$0110,556
(Direct)		View
2023-03-03
Exercise		2023-03-07
4:26 pm		N/A
2026-03-04		SUTRO BIOPHARMA INC.STROChung Jane
Chief Commercial Officer		7,875$0110,556
(Direct)		View
2023-03-03
Tax Withholding		2023-03-07
4:26 pm		N/A
N/A		SUTRO BIOPHARMA INC.STROChung Jane
Chief Commercial Officer		3,211$5.79110,556
(Direct)		View
2022-08-10
Option Award		2022-08-11
6:58 pm		N/A
2032-08-10		Viracta Therapeutics Inc.VIRXChung Jane
Director		80,000$080,000
(Direct)		View
2022-08-09
Tax Withholding		2022-08-10
6:16 pm		N/A
N/A		SUTRO BIOPHARMA INC.STROChung Jane
Chief Commercial Officer		6,483$6.671,017
(Direct)		View
2022-08-09
Exercise		2022-08-10
6:16 pm		N/A
2025-08-09		SUTRO BIOPHARMA INC.STROChung Jane
Chief Commercial Officer		18,750$071,017
(Direct)		View
2022-03-04
Option Award		2022-03-07
7:33 pm		N/A
2032-03-03		SUTRO BIOPHARMA INC.STROChung Jane
Chief Commercial Officer		73,500$073,500
(Direct)		View
2021-08-09
Option Award		2021-08-11
5:21 pm		N/A
2031-08-08		SUTRO BIOPHARMA INC.STROChung Jane
Chief Commercial Officer		235,000$0235,000
(Direct)		View

Ownership		2021-08-11
5:18 pm		N/A
N/A		SUTRO BIOPHARMA INC.STROChung Jane
Chief Commercial Officer		0$00
(Direct)		View